OPKO Health, Inc. (FRA:XCY)

Market Cap	814.18M -15.3%
Revenue (ttm)	547.23M -9.7%
Net Income	-153.75M
EPS	-0.21
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	1.046
Previous Close	1.013
Day's Range	1.046 - 1.046
52-Week Range	1.013 - 1.656
Beta	n/a
RSI	39.13
Earnings Date	Feb 27, 2026

About OPKO Health

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers, ...

• Industry: Medical Laboratories
• Founded: 2007
• Employees: 2,997
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: XCY

Financial Performance

In 2024, OPKO Health's revenue was $713.14 million, a decrease of -17.41% compared to the previous year's $863.50 million. Losses were -$53.22 million, -71.82% less than in 2023.

Financial numbers in USD